Therefore, we hypothesized that the overexpressed SPARC M2 conditioned medium may reduce the activation of the AKT/ mTOR pathway in tumour cells, thereby attenuating the M2-mediated malignant tumour phenotype. This evidence concerns the gene AKT1 and neoplasm.